Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

GreenDigiPharma Green and digital continuous-flow pharmaceutical manufacturing

Coordinator
Politecnico Di Milano, Italy
Runs
1 January 2023 to 31 March 2027
Status
Running
EU funding
€2.6m
Total cost
—
Partners
24 organisations in 12 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101073089

What the project is doing

In the project's own words, from its summary on CORDIS.

Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes. This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments.

The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.

Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.

Topics

Who is involved

OrganisationCityCountryRole
Politecnico Di MilanoMilanoItalyCoordinator
Universiteit GentGentBelgiumParticipant
Vlaamse Instelling Voor Technologisch Onderzoek N.v.MolBelgiumParticipant
Universidade Estadual De CampinasCampinas SpBrazilAssociatedpartner
Chromacon AGZurichSwitzerlandAssociatedpartner
Datahow AGZurichSwitzerlandAssociatedpartner
Deasyl SAPlan Les OuatesSwitzerlandAssociatedpartner
Dalian University of TechnologyDalianChinaAssociatedpartner
Universidad De CordobaCordobaSpainParticipant
Dompe Farmaceutici SpAMilanoItalyAssociatedpartner
Procos SpaCameriItalyAssociatedpartner
Universita Degli Studi Di Bari Aldo MoroBariItalyParticipant
Universita Degli Studi Di MilanoMilanoItalyAssociatedpartner
C2cat BVTer AarNetherlandsAssociatedpartner
Feyecon Development & Implementation BVWeespNetherlandsAssociatedpartner
Symeres Netherlands BVNijmegenNetherlandsAssociatedpartner
Universiteit Van AmsterdamAmsterdamNetherlandsParticipant
King Faisal UniversityAl HofoufSAAssociatedpartner
Astrazeneca ABSodertaeljeSwedenAssociatedpartner
Sartorius Bia Separations, Separacijske Tehnologije, D.o.o.AjdovscinaSloveniaAssociatedpartner
Univerza V LjubljaniLjubljanaSloveniaParticipant
Loughborough UniversityLoughboroughUnited KingdomAssociatedpartner
Uniqsis LtdSheprethUnited KingdomAssociatedpartner
Lawrence Berkeley National Laboratory - Accelerator Technology and Applied Physics DivisionBerkeleyUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI